Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.
Journal: Cancer research communications
Published: July 20, 2026
The PRIME trial: An investigator-initiated, multicentre, phase II study of the poly(ADP-ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)-mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes.
Journal: British journal of haematology
Published: July 02, 2026
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.
Journal: JCO precision oncology
Published: June 17, 2026
Quantitation of Cirtuvivint (SM08502) in Human Plasma by LC-MS/MS.
Journal: Biomedical chromatography : BMC
Published: April 15, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.
Journal: American journal of hematology
Published: December 15, 2025
Exposure to Agent Orange and Association with Myelodysplastic Syndromes.
Journal: Blood advances
Published: December 01, 2025
Exposure to Agent Orange and association with myelodysplastic syndromes.
Journal: Blood advances
Published: December 01, 2025
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.
Journal: The Lancet. Haematology
Published: November 17, 2025
Last Updated: 09/26/2026